The prevalence of hepatitis B surface antigen and antibody in home-reared individuals with Down syndrome.

Researchers drew blood from 180 people with Down syndrome who lived at home. They checked for hepatitis B surface antigen and antibody. They compared results to 155 controls without Down syndrome.

All participants lived in the community, not in institutions. The study aimed to see if Down syndrome alone raised hepatitis B risk.

Hepatitis B markers showed up no more often in the Down syndrome group. Rates matched the general population exactly. Living at home seemed to erase any extra risk.

Ghaziuddin et al. (1996) later pooled data and still listed hepatitis B as a condition to screen for in Down syndrome. Their review gave hepatitis B an elevated odds ratio, which looks like a direct clash with the 1991 null result.

The difference is setting. The 1991 study only tested home-reared people. The 1996 review mixed institutional and community samples. Institutions often have higher hepatitis B rates, so the blended data tipped the odds upward.

Cordova et al. (1993) repeated the experiment in a broader group of handicapped youth who also lived at home. They found the same low 4.2% marker rate, backing up the 1991 finding that community living keeps hepatitis B risk normal.

If your client with Down syndrome lives at home, you can reassure families that hepatitis B risk is ordinary. No extra blood tests are needed beyond standard pediatric care. Save screening resources for higher-risk settings like group homes or institutions.